Tirzepatide Patient Reviews
Real tirzepatide patient reviews. Higher satisfaction than semaglutide in head-to-head comparisons. What patients say about Mounjaro and Zepbound in 2026.
Avg. rating
8.0-8.5/10
Dramatic loss cited
~72% of reviews
Supply complaints
~45% of negatives
Switcher satisfaction
High
Better than expected
~60% report
Overall Satisfaction
Tirzepatide consistently receives high satisfaction ratings, averaging 8.0-8.5 out of 10 on major review platforms. Patients frequently rate it higher than previous GLP-1 experiences, particularly those who switched from semaglutide or liraglutide. The greater average weight loss and potentially better GI tolerance contribute to higher satisfaction scores.
The most common theme in positive reviews is the magnitude of weight loss. Patients who achieve 20%+ body weight loss often describe the experience as life-changing, with improvements in mobility, energy, sleep quality, and overall health that extend far beyond the scale.
What Patients Love
Top praise points include: dramatic weight loss results exceeding expectations (~72% of positive reviews), strong appetite suppression with less nausea than semaglutide (~58%), once-weekly convenience (~45%), improved blood sugar and metabolic markers (~40%), and the wide dose range allowing personalization (~30%).
Patients who switched from semaglutide frequently note that tirzepatide produced additional weight loss beyond what they achieved on semaglutide, even at comparable time periods. The dual mechanism appears to benefit patients who had plateaued on GLP-1-only therapy.
Common Criticisms
The most frequent complaints involve supply and access issues (~45% of negative reviews), cost and insurance hurdles (~40%), GI side effects during titration (~35%), and the injectable-only format (~15%). Supply shortages have been particularly frustrating for patients who experience dose interruptions.
Some patients report that the effectiveness decreases at higher doses or that they plateau before reaching their goal weight. This is consistent with the biological reality that weight loss medications have variable ceilings for different individuals.
Switcher Experiences
Patients who switched from semaglutide to tirzepatide most commonly report renewed weight loss after a semaglutide plateau, potentially better GI tolerance, and satisfaction with the wider dose range. Some note that the transition period involves a brief adjustment as the body adapts to the dual mechanism.
Those who switched from tirzepatide to semaglutide (less common) typically did so due to insurance coverage changes or supply issues. Most report slightly less weight loss but adequate results, suggesting that both medications are effective for most patients.
Frequently Asked Questions
Is Mounjaro better than Ozempic according to patients?
Patients who have tried both generally rate tirzepatide higher for weight loss results. However, individual experiences vary, and some patients prefer semaglutide for tolerability or access reasons.
What do patients say about Zepbound?
Zepbound reviews are overwhelmingly positive regarding weight loss efficacy. The most common complaint is access -- insurance coverage, supply, and cost are frequently mentioned challenges.
How fast do people lose weight on tirzepatide?
Patients commonly report 5-10% weight loss in the first 3 months and 15-20%+ by 6-9 months. The rate varies by dose, adherence, and individual factors.
Read verified provider reviews for tirzepatide programs
Compare pricing, reviews, and availability across 18,000+ GLP-1 providers nationwide.
Search Providers →Explore all Tirzepatide topics
Cost guides, side effect management, dosing information, insurance coverage, and more — all backed by clinical data.